Abstract
Two hundred and ten bronchoalveolar lavage (BAL) samples were obtained from 50 patients 10 days before and on defined days after allogeneic bone marrow transplantation (BMT). The samples were examined for human cytomegalovirus (HCMV) and human herpesvirus-6 (HHV-6) by polymerase chain reaction (PCR). Fifteen patients (30%) had a positive result for HCMV in at least one sample and 25 (50%) were positive for HHV-6 in at least one sample. Five patients developed HCMV-associated interstitial pneumonia (HCMV-IP) within 100 days after allogeneic BMT. Four of these patients were positive for both HCMV and HHV-6. Conspicuous HHV-6 positivity was detected in BAL samples obtained because of respiratory symptoms. No association was found between detection of HHV-6 and acute graft-versus-host disease. Engraftment failure or a delay in engraftment was observed in none of the 50 patients. The data from this study indicate that HHV-6 is a pathogen in HCMV-associated, as well as in non-HCMV-associated infectious lung disease after BMT. Bone Marrow Transplantation (2000) 26, 639–644.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wingard JR, Mellits ED, Sostrin MB et al. Interstitial pneumonitis after allogeneic bone marrow transplantation Medicine 1988 67: 175–185
Carrigan DR, Drobyski WR, Russler S et al. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation Lancet 1991 338: 147–149
Salahuddin SZ, Ablashi DV, Markham PD et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders Science 1986 243: 596–600
Knowles WA, Gardner SD . High prevalence of antibody to human herpesvirus-6 and seroconversion associated with rash in two infants Lancet 1988 2: 912–913
Yamanishi K, Okuno T, Shiraki K et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum Lancet 1988 14: 1065–1391
Akashi K, Eizura Y, Sumiyoshi Y et al. Severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult New Engl J Med 1993 2: 168–171
Kirchesch H, Mertens T, Burkhardt U et al. Seroconversion against human herpesvirus-6 (and other herpesviruses) and clinical illness Lancet 1988 30: 273–274
Kehl Knox K, Carrigan DR . Disseminated active HHV-6 infections in patients with AIDS Lancet 1994 5: 577–578
Krueger GRF, Wassermann K, De Clerk LS et al. Latent herpesvirus-6 in salivary and bronchial glands Lancet 1990 336: 1255–1256
Kondo K, Kondo T, Okuno T et al. Latent human herpesvirus 6 infection of human monocytes/macrophages J Gen Virol 1991 72: 1401–1408
Wrzos H, Gibbons J, Abt PL et al. Human herpesvirus 6 in monocytes of transplant patients Lancet 1990 335: 486–487
Campadelli-Fiume G, Mirandola P, Menotti L . Human herpesvirus 6: an emerging pathogen Emerg Infect Dis 1999 5: 353–366
Ablashi DV, Balahandran N, Josephs SF et al. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates Virology 1991 184: 545–552
Drobyski WR, Eberle M, Majewski D et al. Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridisation J Clin Microbiol 1993 31: 1515–1520
Frenkel N, Katsafanas GC, Wyatt LS et al. Bone marrow transplant recipients harbor the B variant of human herpesvirus 6 Bone Marrow Transplant 1994 14: 839–843
Rosenfeld CS, Rybka WB, Weinbaum D et al. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6 Exp Hematol 1995 23: 626–629
Drobyski WR, Kehl Knox K, Majewski D et al. Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow transplant recipient New Engl J Med 1994 330: 1356–1360
Carrigan DR, Kehl Knox K . Human herpesvirus (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients Blood 1994 84: 3307–3310
Wilborn F, Brinkmann V, Schmidt CA et al. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction Blood 1994 83: 3052–3058
Beelen DW, Quabeck K, Kaiser B et al. Six weeks of continuous intravenous cyclosporine and short course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation Transplantation 1990 50: 421–427
Gluckberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304
Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation New Engl J Med 1975 292: 895–902
Sambrook J, Fritsch EF, Maniatis T . Molecular Cloning: A Laboratory Manual, second edn Cold Spring Harbor Laboratory, New York 1989
Kwok S, Higuchi R . Avoiding false positives with PCR Nature 1989 339: 237–238
Slandin RL, Rodriguez ER, Rosenberg E et al. Comparison of sensitivity for human cytomegalovirus of the polymerase chain reaction, traditional tube culture and shell vial assay by sequential dilutions of infected cell lines J Virol Methods 1991 32: 181–191
Portolani M, Fabio G, Pecorari M et al. Search for human herpesvirus 6 and human cytomegalovirus in bronchoalveolar lavage from patients with human immunodeficiency virus-1 and respiratory disorders J Med Virol 1996 48: 179–183
Goto H, Sakamaki H, Nakata K et al. Rapid detection of cytomegalovirus pneumonia in recipients of bone marrow transplant: evaluation and comparison of five survey methods for bronchoalveolar lavage fluid Bone Marrow Transplant 1996 17: 855–860
Yoshikawa T, Suga S, Asano Y et al. Human herpesvirus-6 infection in bone marrow transplantation Blood 1991 78: 1381–1384
Russler SK, Tapper MA, Kehl Knox K et al. Pneumonitis associated with coinfection by human herpesvirus 6 and Legionella in an immunocompetent adult Am J Path 1991 138: 1405–1411
Irving WL, Ratnamohan VM, Hueston LC et al. Dual antibody rises to cytomegalovirus and human herpesvirus type 6: frequency of occurrence in CMV infections and evidence for genuine reactivity to both viruses J Infect Dis 1990 161: 910–916
Taylor-Wiedeman J, Sissons JGP, Borysiewicz LK et al. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells J Gen Virol 1991 72: 2059–2064
Schonnebeck M, Krueger G, Braun M et al. Human herpesvirus-6 infection may predispose cells to superinfection by other viruses In Vivo 1991 5: 255–264
Flamand L, Stefanescu I, Ablashi D et al. Activation of the Epstein–Barr virus replicative cycle by human herpesvirus 6 J Virol 1993 67: 6768–6777
Kadakia MP, Rybka WB, Stewart JA et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation Blood 1996 87: 5341–5354
Wang F-Z, Dahl H, Linde A et al. Lymphotrophic herpesviruses in allogeneic bone marrow transplantation Blood 1996 88: 3615–3620
Acknowledgements
We acknowledge Dr K Quabeck for performing the bronchoalveolar lavage.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buchbinder, S., Elmaagacli, A., Schaefer, U. et al. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 26, 639–644 (2000). https://doi.org/10.1038/sj.bmt.1702569
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702569